Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy

Gabriela Godaly; Ola Carlsson; Marcus Broman

doi:10.1093/ckj/sfv133

Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy

Gabriela Godaly, Ola Carlsson, Marcus Broman

Research output: Contribution to journal › Article › peer-review

Abstract

Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (

Original language	English
Pages (from-to)	205-210
Number of pages	6
Journal	Clinical Kidney Journal
Volume	9
Issue number	2
DOIs	https://doi.org/10.1093/ckj/sfv133
Publication status	Published - 2016 Apr 1

Subject classification (UKÄ)

Clinical Medicine

Free keywords

critically ill patients
CRRT
hypophosphataemia
intensive care medicine

Access to Document

10.1093/ckj/sfv133

Cite this

@article{d9a36a3d8e114070bd86cbd3135a44ea,

title = "Phoxilium{\textregistered} reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy",

abstract = "Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol{\textregistered} B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium{\textregistered} (phosphate; n = 76) as dialysis fluid and Hemosol{\textregistered} B0 as replacement fluid. Results Hypophosphataemia (",

keywords = "critically ill patients, CRRT, hypophosphataemia, intensive care medicine",

author = "Gabriela Godaly and Ola Carlsson and Marcus Broman",

year = "2016",

month = apr,

day = "1",

doi = "10.1093/ckj/sfv133",

language = "English",

volume = "9",

pages = "205--210",

journal = "Clinical Kidney Journal",

issn = "2048-8505",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy

AU - Godaly, Gabriela

AU - Carlsson, Ola

AU - Broman, Marcus

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (

AB - Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (

KW - critically ill patients

KW - CRRT

KW - hypophosphataemia

KW - intensive care medicine

U2 - 10.1093/ckj/sfv133

DO - 10.1093/ckj/sfv133

M3 - Article

C2 - 26985370

AN - SCOPUS:84963946824

SN - 2048-8505

VL - 9

SP - 205

EP - 210

JO - Clinical Kidney Journal

JF - Clinical Kidney Journal

IS - 2

ER -

Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy

Abstract

Subject classification (UKÄ)

Free keywords

Access to Document

Fingerprint

Cite this